Jefferies Group’s Guardant Health GH Stock Holding History

Jefferies Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.7M	Sell	50,228 -13,805	-22%	-$709K	0.02%	511
2022 Q2	$2.58M	Buy	64,033 +58,148	+988%	+$2.88M	0.02%	531
2022 Q1	$390K	Sell	5,885 -7,968	-58%	-$545K	﹤0.01%	1117
2021 Q4	$1.39M	Buy	13,853 +7,732	+126%	+$800K	0.01%	906
2021 Q3	$765K	Sell	6,121 -26,914	-81%	-$3.2M	0.01%	1093
2021 Q2	$4.1M	Buy	33,035 +4,287	+15%	+$577K	0.03%	520
2021 Q1	$4.39M	Sell	28,748 -2,052	-7%	-$310K	0.04%	424
2020 Q4	$3.97M	Buy	30,800 +27,758	+912%	+$3.19M	0.03%	486
2020 Q3	$340K	Sell	3,042 -24,458	-89%	-$2.24M	﹤0.01%	1073
2020 Q2	$2.23K	Buy	+27,500	New	+$2.22M	0.03%	515
2019 Q4	–	Sell	-28,071	Closed	-$1.79M	–	2707
2019 Q3	$1.79M	Buy	28,071 +24,011	+591%	+$2.12M	0.01%	1159
2019 Q2	$350K	Sell	4,060 -1,140	-22%	-$87.1K	﹤0.01%	1849
2019 Q1	$399K	Buy	+5,200	New	+$288K	﹤0.01%	1689

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jefferies Group's GH Position: Q3 2022 in Review

Jefferies Group reduced its Guardant Health (GH) stake by 22% in Q3 2022, selling an estimated $709K and leaving 50,228 shares worth $2.7M. The position accounts for 0.02% of the portfolio, ranked #511.

Jefferies Group first reported a position in GH in Q1 2019 and has held it in 13 quarters since. The position peaked at $4.39M in Q1 2021. 327 funds tracked by Wall St. Rank hold GH as of Q3 2022.

Jefferies Group held 50,228 shares of Guardant Health worth $2.7M as of Q3 2022.
Jefferies Group sold 13,805 Guardant Health shares in Q3 2022, an estimated $709K.
Guardant Health made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #511 holding.
Jefferies Group first reported a position in Guardant Health in Q1 2019 and has held it in 13 quarters since.
Jefferies Group's Guardant Health position peaked at $4.39M in Q1 2021.
327 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.